Matthew Levy
Papers
2
Total Citations
109
H-Index
2
About
Matthew Levy is a molecular biologist and biochemist whose research has significantly advanced the fields of aptamer technology and nucleic acid engineering. His pioneering work focuses on the development and application of functional nucleic acids — particularly RNA and DNA molecules capable of performing highly specific binding and catalytic activities. Levy's 2004 paper, "Functional RNA Microarrays for High-Throughput Screening of Antiprotein Aptamers," garnered 87 citations and represented a landmark contribution to the field, demonstrating how microarray platforms could be harnessed to rapidly identify RNA aptamers with high specificity for protein targets. This work opened new avenues for drug discovery and diagnostic tool development. His earlier research, "Toward Automated Nucleic Acid Enzyme Selection" (2001), helped lay the groundwork for streamlining the SELEX process through laboratory automation, successfully isolating nanomolar-affinity binding species and advancing deoxyribozyme selection methodologies. Together, these contributions reflect Levy's commitment to making nucleic acid selection faster, more scalable, and more accessible — work that continues to influence researchers developing biosensors, therapeutics, and molecular tools across biochemistry and biomedical science.
Research Focus
Key Achievements
Top Papers
- 1
- 2Toward Automated Nucleic Acid Enzyme Selection22 citations · 2001